Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2005
02/24/2005US20050042706 Methods for the identification of inhibitors of porphobilinogen deaminase as antibiotics
02/24/2005US20050042705 Methods for the identification of inhibitors of mannosyltransferase as antibiotics
02/24/2005US20050042703 Method for quantitating triglycerides in lipoproteins
02/24/2005US20050042698 Using mass/charge signature of unbound heme to diagnose malarial parsite infection
02/24/2005US20050042695 For detecting and analyzing oxidized polypeptides, nucleic acids, lipids, and polysaccharides; kits; neurodegenerative/neoplastic/vascular/autoimmune disorders
02/24/2005US20050042685 Using bispecific antibodies comprising magnetic particle to separate and identify tumorigenic testicular tissue in solution
02/24/2005US20050042676 Contacting sample with lysine selective agent to cap epsilon -amino group, digesting sample to produce peptide fragments, deactivating cleavage reagent, deblocking/deprotecting, then recovering fragments; solid phase synthesis; kits
02/24/2005US20050042673 Method and compositions for ordering restriction fragments
02/24/2005US20050042671 Modulation of angiogenesis
02/24/2005US20050042668 Using electrophoretic DNA data as diagnostic tool in gene discovery, genetic diagnosis, drug discovery and forensic analysis
02/24/2005US20050042666 Primers and methods for the detection and discrimination of nucleic acids
02/24/2005US20050042665 Using fluorescent biopolymers as tools in detection of preferential nucleotide sequences; gene expression analysis; genomics
02/24/2005US20050042663 Generating mathematical model which represent biochemical pathways; rational drug design and cell signaling
02/24/2005US20050042662 For tracing/imaging molecular transfer between cellular gap junctions
02/24/2005US20050042661 Quaternary ammonium compounds for rapidly distinguishing cellular components
02/24/2005US20050042658 Array-based epitope-captured antibody display
02/24/2005US20050042657 Using paired-like homeobox 2b (PHOX2b) gen sequences as diagnostic tools in diagnosis and prevention of respiratory system disorders
02/24/2005US20050042656 Room temperature elution of nucleic acids
02/24/2005US20050042655 Using hematopoietoic regulatory related polypeptide (HEMA) for use in diagnosis, treatment and prevention of hematopoietic disorders
02/24/2005US20050042654 System for identifying single nucleotide polymorphisms in preferental allelic sequence; sequence determination
02/24/2005US20050042653 Human transport protein homologs
02/24/2005US20050042650 EN2 gene, diagnostic and therapeutic uses thereof
02/24/2005US20050042649 Arrayed biomolecules and their use in sequencing
02/24/2005US20050042648 Vitro sorting method
02/24/2005US20050042647 Phosphorous-linked oligomeric compounds and their use in gene modulation
02/24/2005US20050042645 Expression vector comprising nucleotide sequences coding nitric oxide synthase for use in preparation of herbicides, antibiotics, nematicides, fungicides, insecticides and anticancer agents
02/24/2005US20050042644 Mobility-modified nucleobase polymers and methods of using same
02/24/2005US20050042642 Using breast cancer gene expression as diagnostic indicator of cell proliferative disorders; antitumor agents
02/24/2005US20050042641 In vivo high throughput selection of RNAi probes
02/24/2005US20050042640 Using stem loop structures to generate three dimensional computer models of single stranded polynucleotide during translation
02/24/2005US20050042639 Single molecule amplification and detection of DNA length
02/24/2005US20050042638 Oligonucleotides comprising a molecular switch
02/24/2005US20050042636 Using semaphorin-5 gene expression as diagnostic indicator of cell proliferative disorders; tissue engineering; tissue targeted therapy
02/24/2005US20050042635 Prophylactic and therapeutic benefits of a new class of immune stimulating peptides
02/24/2005US20050042634 B. anthracis prevention and treatment: mutant B. anthracis lacking luxS activity and furanone inhibition of growth, AI-2 quorum sensing, and toxin production
02/24/2005US20050042633 Composition and method for nucleic acid sequencing
02/24/2005US20050042632 (Monoclonal) antibodies having binding affinity for a nucleic acid molecule having a 2'-deoxy-2'-C-allyl Uridine nucleoside and/or nucleotide; short interference RNA; drug screening; bioavailability
02/24/2005US20050042630 using gene-specific and/or tissue-specific primers; diagnostic/prognostic test for disease; pharmacogenetics
02/24/2005US20050042628 Methods for concurrently processing multiple biological chip assays
02/24/2005US20050042627 Mixture for ennhancing replication of nuclelotide sequence at low temperatures; DNA amplification
02/24/2005US20050042625 Microarray comprised of nucleotide sequences linked to nicotinic, sinapinic and/or cinnamic acids for use as tool in determining sequence of preferenial nucleic acid molecules
02/24/2005US20050042623 Microarray comprising an immobilized addressed collection of polypeptide-tagged molecules for use as tool in evaluating and monitoring intracellular and extracellular biological activities
02/24/2005US20050042622 Using microarray chips for gene expression monitoring, profiling, library screening and genotyping
02/24/2005US20050042621 Using microarray hybridization as tool in monitoring genic expression; disease diagnostics and gene expression variation
02/24/2005US20050042618 Fluorescent resonance energy transfer probes
02/24/2005US20050042617 Dna detection using primers hybridizing to non-fragmented dna
02/24/2005US20050042615 Colloids formed at interface between streams of reducing agent and metal salt; suface enhanced raman scattering (SER(R)s)
02/24/2005US20050042614 Point mutations; dipeptidyl-peptidase inhibitors; kits
02/24/2005US20050042613 Nucleic acids having expression differentails between hepatoblastoma and normal liver
02/24/2005US20050042611 Diagnosing bone disorder via presence of mutation in protein kinase c interacting protein; bioassay and disease detection
02/24/2005US20050042610 Method and support for biological analysis using oligonucleotides comprising a marker capable of enzymatic activation
02/24/2005US20050042609 Using variation in signal ratios from fluorescent probes to detect chromosomal aberration; prenatal diagnosis of genetic disorders
02/24/2005US20050042608 Detection of single nucleotide polymorphisms
02/24/2005US20050042606 Specific and universal probes and amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
02/24/2005US20050042605 Using presence of long terminal repeat mutation in lymphadenopathy associated viral sequences as diagnostic indicator of viricidal drug resistance
02/24/2005US20050042604 Novel nucleic acid-based tracers and their uses thereof
02/24/2005US20050042603 Protein fusion comprising nuclear localization signal domain for use as tool to enhance gene transfer into cells: gene therapy and heterologous gene expression
02/24/2005US20050042602 Monitoring immunologic, Hematologic and inflammatory diseases
02/24/2005US20050042601 Detection of herpes simplex virus types 1 and 2 by nucleic acid amplification
02/24/2005US20050042597 Viral detection system
02/24/2005US20050042596 Process for examining membrane enclosed biocompartments
02/24/2005US20050042273 Covalently linking PDGF Nucleic Acid Ligand with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound to form a Complex; diagnostic and therapeutic agent; improving pharmacokinetic properties
02/24/2005US20050042228 Method and pharmaceutical composition for the treatment of immune disorders
02/24/2005US20050042214 Discovery of the microorganism that causes the human autoimmune disease, primary biliary cirrhosis
02/24/2005US20050042213 Administering rhodanine derivative and O,O*-dihydroxybenzenebis(p-amidophenol) derivative; metabolic, neurodegenerative and autoimmune diseases; wound healing, antiinflammatory, and anticarcinogenic agents; atherosclerosis, restenosis, nephropathy
02/24/2005US20050042209 Enhancing the induction apoptosis in a MUC1 expressing cancer cell by a pro-apoptotic drugs; antiproliferative agents
02/24/2005US20050042201 Synergistic mixture of glycoprotein and angiogenesis inhibitor comprising angiostatin, thrombostatin, endostatin, interferon, interferon-inducible factor 10, platelet factor, and/or cyclooxygenase inhibitor; antitumor and anticarcinogenic agents
02/24/2005US20050042143 Plastic plate and plastic plate assembly
02/24/2005US20050040550 High throughput screening for novel bioactivities
02/24/2005US20050040483 Fet sensor with specially configured gate electrode for the highly sensitive detection of analytes
02/24/2005US20050040044 System of handling dielectric particles, particularly biological cells, by means of dielectrophoresis
02/24/2005US20050040043 Receptor binding assay to separate and purifying the target DNA or RNA molecules from a sample
02/24/2005DE10336511A1 In vitro detection of systemic inflammatory response syndrome and related conditions, for e.g. monitoring progression, comprises detecting abnormal expression of disease-related genes
02/24/2005DE10242183A1 Detecting single-stranded nucleic acid, useful e.g. for sequence analysis and therapy, based on the catalytic effect, on electrochemical reactions, of single-stranded, but not double-stranded, nucleic acid
02/24/2005DE102004027865A1 Manufacture of conductive carbon nanotubes dotted with metals for biosensors, involves combining carboxyl group of nanotube with amino group of substance having amino and thiol groups, and combining metal with thiol group
02/24/2005CA2536235A1 Coronavirus, nucleic acid, protein, and methods for the generation of vaccine, medicaments and diagnostics
02/24/2005CA2536150A1 Active-site titration of glycosyl hydrolases
02/24/2005CA2535984A1 C1-inh as a drug for treating viruses pathogenic to humans
02/24/2005CA2535910A1 Methods and compositions for detecting colon cancers
02/24/2005CA2535901A1 Ups as modifiers of the beta catenin pathway and methods of use
02/24/2005CA2535897A1 Sulfs as modifiers of the beta catenin pathway and methods of use
02/24/2005CA2535812A1 Prkcs as modifiers of the beta catenin pathway and methods of use
02/24/2005CA2535808A1 Melks as modifiers of the rac pathway and methods of use
02/24/2005CA2535805A1 Multifactorial assay for cancer detection
02/24/2005CA2535602A1 Methods and kits for preparing nucleic acid samples
02/24/2005CA2535332A1 Method for rapid identification of alternative splicing
02/24/2005CA2535255A1 Improved halohydrin dehalogenases and related polynucleotides
02/24/2005CA2534897A1 Process of making flowable hemostatic compositions and devices containing such compositions
02/24/2005CA2534895A1 Hemostatic compositions containing sterile thrombin
02/24/2005CA2534629A1 Engineered proteases for affinity purification and processing of fusion proteins
02/24/2005CA2533924A1 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels
02/24/2005CA2533910A1 Methods and compositions for amplification of dna
02/24/2005CA2533500A1 Use single nucleotide polymorphsm in the coding region of the porcine leptin receptor gene to enhance pork production
02/24/2005CA2532557A1 Methods and compositions for determination of glycated proteins
02/24/2005CA2531253A1 Sir2 regulation
02/24/2005CA2530748A1 Methylated gene biomarkers for detecting cancer
02/24/2005CA2530401A1 Enzymatic diagnostic test for sars and other viral diseases
02/24/2005CA2528843A1 System for detecting polynucleotides
02/24/2005CA2525969A1 Intron fusion proteins, and methods of identifying and using same
02/24/2005CA2524194A1 Method and kit for identifying antibiotic-resistant microorganisms